Antioxidative Effect of Silymarin and Silybin Purified from Silybum marianum on Oxidation of Human Low Density Lipoprotein by Macrophages

Korean Journal of Applied Microbiology and Biotechnology

Volumn 25, Issue 3, 1997, Pages 286-292

  Lee, Baek Chen ^b   Jeong, Yong Kee ^c   Ryu, Beung Ho ^a  

^a Kyungsung University   (South Korea)

^b Samchundang Pharm Co Ltd   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

Low density lipoprotein; Silybin; Silymarin

Indexed keywords

EID: 1842484325     PISSN: 02572389     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Harborne, J. B., T. J. Mabry, H. Mabry, 1975. The flavonoids. London: Chapman and Hall.
2. Herrmann, K. 1976. Flavonols and flavones in plants. A review. J. Food Technol. 11: 433-448.
3. Kuhnau, J. 1976. The flavonoids. A class of semi-essential food components. Their role in human nutrition. World Rev. Nutr. Diet., 24: 117-191.
4. Pierpoint, W. S. 1986. Flavonoids in the human diet. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships. p. 125-140, Alan R. Liss, New York, NY USA.
5. Cody, V. 1988. Crystal and molecular structure of flavonoids. In Plant Flavonoids in Biology and Medicine II. Biochemical, Cellular, and Medicinal Properties, p. 29-44, Alan R. Liss, New York, NY USA.
6. Middleton, E., Jr. and C. Kandswami, 1993. The impact of plant flavonoids on mammalian biology. Implications for immunity, inflammation and cancer. In the Flavonoids. Advances in Research Since 1986. (J.B. Harborne, ed.), p. 619-652, Chapman and Hall, London, UK.
7. Ratty, A. K. and N. P. Das, 1988. Effects of flavonoids on nonenzymic lipid peroxidation. Structure activity relationship. Biochem. Med. Metabol. Biol. 39: 69-79.
8. Hackett, A. M. 1986. The metabolism of flavonoid compounds in mammals. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structural Activity Relationships. p. 177-194, Alan R. Liss, New York, NY. USA.
9. Das, N. P., ed. 1990. Flavonoids in biology and medicine III-Curent issues in flavonoids research. Singapore: Singapore University Press.
10. Kandaswami, C. 1994. Middleton, E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv. Exp. Med. Biol. 366: 351-376.
11. Nonaka, G., L. Nishioka, M. Nishizawa., T. Yamagishi, Y. Kashiwada, G. E. Dutschman, A. J. Bodner, R. E. Kilkuskie, Y.-C. Cheng and K.-H. Lee, Anti-AIDS agents 2. 1990. Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. J. Natl. Prod. 53: 587-595.
12. Nakane, H. and K. Ono, 1990. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 29: 2841-2845.
13. Middleton, E. and C. Kandaswami, 1992. Effests of flavonoids on immune and inflammatory functions. Biochem. Pharmacol. 43: 1167-1179.
14. Sudina, G. F., O. K. Mirzoeva, M. A. Pushkareva, G. A. Korshunova, N. V. Sumbutya and S. D. Varfolomeev, 1993. Caffeic acid phenethyl ester as a lipoxygengenase inhibitor with antioxidant properties. FEBS Lett. 329: 21-24.
15. Ho, C.-T., Q. Chen, H. Shi, K.-Q. Zhang and R. T. Rosen, 1992. Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev. Med. 21: 520-525.
16. Kinsella, J. E., E. Frankel, B. German and J. Kanner, 1993 Possible mechanisms for the protective role of antioxidants in wine and plant foods. Food Technol. April: 85-8
17. Namiki, M. 1990. Antioxidants/antimutagens in food. Crit. Rev. Food Sci. Nutr. 29: 273-300.
18. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo and J. L. Witztum, Beyond cholesterol. 1989. Modification of low-density lipoprotein that increases its atherogenicity. New Engl. J. Med, 320: 915-924.
19. Greenspan, P., B. H. Ryu, F. Mao and R. L. Gutman, 1995. Association of megatively-charged phospholipids with low density lipoprotein (LDL) increasesit uptake and the deposition of cholesteryl esters by macrophages, Biochim. Biophy. Acta., 1257: 257-264.
20. Ross., R. 1989. The pathogenesis of atherosclerosis: perspective for the 1990'S, Nature., 362. 801-809, 1993.2) Steinberg D., Parthasarathy S., Carew T. E., J. C Khoo, J. L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N. Engl. J. Med., 320: 915-924.
21. Ross., R. 1989. The pathogenesis of atherosclerosis: perspective for the 1990'S, Nature., 362. 801-809, 1993.2) Steinberg D., Parthasarathy S., Carew T. E., J. C Khoo, J. L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N. Engl. J. Med., 320: 915-924.
22. Esterbauer, H., M. Dieber-Rotheneder, G. Waeg and G. Striegl. 1990. Biochemical, structural and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol., 3, 77-92.
23. Greenspan, P., R. L. Gutman, F. Mao, B. H. Ryu and P. Low, 1996. Iron-ascorbate-phospholipiu mediated modification of low density lipoprotein, Biochim. Bioph. Acta, 1301: 242-248.
24. Carpenter, K. L. H., C. E. Brabbs and M. J. Mitchinson, 1991. Oxygen radicals and atherosclerosis. Klin Wochenschr., 69: 1039-1045.
25. Henriksen, T., E. Mahoney and D. Steinberg, 1981. Enhanced macrophage degradation of low density lipoportein previously incubated with cultured endothelial cells. Recognition by the receptor for acetylated low density lipoprotein. Proc. Natl. Acad. Sci., USA. 78: 6499-6503.
26. Henriksen, T., E. M. Mahoney and D. Steinberg, 1983. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis., 3: 149-159.
27. Morel, D. W., P. E. Docorleto and G. M. Chisolm, 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arterloscerosis 4: 357-364.
28. Ryu, B. H., F. W. Mao, P. Lou, R. L. Gutman and P. Greenspan, 1995. Cholesteryl ester accumulation in macrophages treated wity oxidized low density lipoprotein, Biosci. Biotech. Biochem., 59: 1619-1662.
29. Heinecke, J. W., H. Rosen and A. Chait, 1984. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest., 74: 1890-1894.
30. Steinbrecher U., S. Parthasarathy, D. S. Leake, J. L. Witztum and D. Steinberg, 1984. Modification of low density lipoprotein by endothelial cells nvolves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci., USA, 83: 3883-3887.
31. Bruckdorfer, K. R. 1990. Free radicals, lipid peroxidation and atherosclerosis. Curr. Opin. Lipidol., 1: 529-535.
32. Esterbauer H., H. Puhl, M. Dieber-Rotheneder, G. Srriegl and G. Waeg, 1991. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am. J. Clin. Nutr., 53: 314S-321S.
33. Mao, S. J. T. and M. T. Yates, 1989(abstract). Antioxidant activity of probucol and vitamin E(α-tocopherol) in plasma. Artheriosclerosis 9: 751 a.
34. Esterbauer, H., G. Streigel, H. Puhl, S. Oberreither, M. Rotherneder, M. El-Saadani and G. Urgens, 1989. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann. N. Y. Acad. Sci., 570: 254-267.
35. Mangiapane, H., J. Thomson, A. Salter, S. Brown, G. D. Bell, and D. A. White, 1992. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem. Pharmacol., 43: 445-450.
36. De Whalley, C. V., S. M. Rankin, J. R. S. Hoult, W. Jessup, and D. S. Leake, 1990. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol., 39: 1743-1750.
37. Machlin, L. J. and A. Bendich, 1987. Free radical tissue damage: Protective role of antioxidant nutrients. FASEB J., 1: 441-445.
38. Salmi, H. A. and S. Sarna, 1982. Effect of silymarin on chemical, functional, and morphological alterations of the liver. Scand. J. Gastroenterol., 17: 517-521.
39. 4. Arzneimitteforsch, 23: 148-149.
40. Rauen, H. M. and H. Schriewer, 1971. Die antihepatotoxische Wirkung von Silymarin bei experimentellen Leberschagungen der Ratte durch Tatrachlorkohlen stoff. D-Galaktosamin und Allylalkohol., Arzneiminelforsch, 21: 1194-1201.
41. 4-induced cirrhosis by silymarin. Fund. Clin. Pharmacol., 3: 183-192.
42. Ferenci, P, B. Dragosics, H. Dittrich, H. Frank, L. Benda, H. Lochs, S. Meryn, W. Base, and B. Schneider, 1989. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J. Hepatol 9: 105-113.
43. Nikino, N., Y. Kiso, H. Wagner, and M. Fiebig, 1984. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits, Planta Med., 50: 248-250.
44. 4 liver damage. J. Appl. Toxicol., 10: 275-279.
45. Havel, R. J., H. A. Eder. and J. H. Bragdon, 1995. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1352.
46. Jaffe, E. A., R. L. Nackman, C. G. Becker and C. R. Minick, 1973. Culture of human endothelial cells derived from umbilical veins. J Clin. Invest., 52: 2745-2756.
47. Van Hinsberg, V. W. M., I. Havekes., J. J. Eneis, E. Van Corven, and M. Scheffer, 1983. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins, Arteriosclerosis 3: 547-559.
48. McCorron, R. M., D. K. Goroff, J. E. Luhr, M. A. Murphy and H. B. Herscowitz, 1984. Methods for the collection of peritoneal and alvaela macrophages, Methods Enzymol., 108: 274-284.
49. Mac Farland, A. S., 1956. Efficient trace-labeling of proteins with iodide, Nature, 182: 158.
50. Esterbauer, H., G. Striegl, H. Puhl and M. Rotheneder, 1989, Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6: 67-75.
51. Yaki, K. 1976. A. simple fluorometric assay for lipoperoxide in blood plasma. Biochem., Med., 15: 212-217.
52. Greenspan, P. and JR. L. Gutman, 1993. Detection by nile red of agarose gel electrophoresed native and modified low density lipoprotein. Electrophoresis 14: 65-68.
53. Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J. Randell, 1951. Protein measurement with the Folin phenol reagent., J. Biol. Chem., 193: 265-275.
54. Ruch, R. J., S. J. Cheng and J. E. Klauning, 1986. Prevention of cytotoxicity and ingibition of intracellalar communication by antioxidant catechins isolated from chinese green tea, Carcinogenesis, 10: 1003-1008.
55. Jiala, I. and C. Scaccini, 1992. Antioxidants and atherosclerosis. Current opin. Lipidologe. 3: 324-330.
56. Rankin, S. M., S. Parthasarathy and D. Steinberg, 1991. Evidence for a dominant role of lipoxygenase(5) in the oxidation of low density lipoprotein by mouse peritoneal macrophage, J. Lipid Res., 32: 449-454.
57. Kuzuga, M. and F. Kuzuza, 1993. Probucol as an antioxidant and antiatherogenic drug, Free Rad. Biol. med., 14: 66-67.